STRYKER CORP 2019-03.12.24STRYKER CORP 2019-03.12.24STRYKER CORP 2019-03.12.24

STRYKER CORP 2019-03.12.24

No trades
See on Supercharts

A2SA1V analysis



Key facts


Issue date
Dec 3, 2019
Maturity date
Dec 3, 2024
Outstanding amount
‪850.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
0.25% (Fixed)
Yield to maturity
1.71%
Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.